An indigenously developed CAR T-cell gene therapy has achieved a 73% response rate for certain blood cancers in India. The ...
Taiho Pharmaceutical Co., Ltd. (hereinafter "Taiho Pharmaceutical") and Araris Biotech AG (hereinafter "Araris"), a Swiss biotechnology company developing next-generation antibody drug conjugates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback